Nymox Pharmaceutical Corp ROIC
Quel est le ROIC de Nymox Pharmaceutical Corp?
Le ROIC de Nymox Pharmaceutical Corp est -238.41%
Quelle est la définition de ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC des entreprises dans Health Care secteur sur NASDAQ par rapport à Nymox Pharmaceutical Corp
Que fait Nymox Pharmaceutical Corp?
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
Entreprises avec roic similaire à Nymox Pharmaceutical Corp
- Annovis Bio a ROIC de -243.15%
- Crown ElectroKinetics a ROIC de -242.81%
- AzurRx BioPharma Inc a ROIC de -242.21%
- Caeneus Minerals Ltd a ROIC de -242.07%
- Yield10 Bioscience Inc a ROIC de -241.08%
- EV Nickel a ROIC de -238.83%
- Nymox Pharmaceutical Corp a ROIC de -238.41%
- BioForce Nanosciences a ROIC de -238.21%
- Tryp Therapeutics a ROIC de -237.27%
- Weebit Nano a ROIC de -236.32%
- Pathfinder Minerals Plc a ROIC de -235.40%
- Highmark Interactive Inc a ROIC de -233.72%
- DynaCERT a ROIC de -233.21%